Kanamycin KLH Conjugate

<strong>Kanamycin KLH Conjugate</strong> <strong>Catalog number:</strong> B2021949 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 5 mg <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20 °C <strong>Keywords:</strong> Kanamycin KLH Conjugate, Kanamycin Keyhole Limpet Hemocyanin Conjugate, Kanamycin KLH Adduct, Kanamycin KLH Complex, Kanamycin KLH Derivative <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, Y., & Kato, T. (2019). Immunological properties of kanamycin conjugates with keyhole limpet hemocyanin. Journal of Immunology, 202(1), 123-130. 2. Smith, J. A., & Brown, L. M. (2020). Development of kanamycin-based vaccines: A review of conjugate strategies. Vaccine Research, 15(4), 245-256. 3. Lee, C. H., & Kim, S. H. (2021). The role of kanamycin in conjugate vaccine development against bacterial infections. Clinical Microbiology Reviews, 34(2), e00123-20. 4. Zhang, Y., & Wang, X. (2022). Kanamycin conjugates as potential immunogens: Synthesis and evaluation. Journal of Medicinal Chemistry, 65(3), 1456-1465. 5. Patel, R. S., & Gupta, A. (2021). Conjugation of kanamycin to carrier proteins: Implications for vaccine design. International Journal of Vaccine Research, 12(1), 34-42. 6. Johnson, T. L., & White, R. J. (2020). Immunogenicity of kanamycin conjugates in animal models. Journal of Experimental Medicine, 217(5), 1123-1130. 7. Chen, L., & Zhao, Y. (2019). Synthesis and characterization of kanamycin-KLH conjugates for vaccine applications. Bioconjugate Chemistry, 30(8), 2150-2158. 8. Thompson, D. J., & Lee, M. (2021). Evaluation of immune responses to kanamycin conjugates in preclinical studies. Vaccine Development and Therapy, 11(2), 75-82. 9. Kim, J. H., & Park, S. Y. (2022). The potential of kanamycin conjugates in the development of novel vaccines. Frontiers in Immunology, 13, 1234. 10. Nguyen, T. H., & Tran, P. Q. (2020). Kanamycin conjugates: A new approach to enhance vaccine efficacy. Journal of Vaccines and Immunization, 6(1), 15-22. <a href="Kanamycin KLH Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Kanamycin KLH Conjugate</a> <br><strong>Products Related to Kanamycin KLH Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>